TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Saniona AB ( (SE:SANION) ).
Saniona AB has announced the composition of its Nomination Committee for the Annual General Meeting 2026, which will include representatives appointed by the company’s two largest shareholders and the Chairman of the Board. The committee is tasked with preparing proposals for the election of board members and other key roles, as well as remuneration and auditor appointments, which will be presented at the meeting in May 2026.
The most recent analyst rating on (SE:SANION) stock is a Buy with a SEK15.50 price target. To see the full list of analyst forecasts on Saniona AB stock, see the SE:SANION Stock Forecast page.
More about Saniona AB
Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders. The company’s internal pipeline includes treatments for epilepsy and major depressive disorder, and it has established strategic collaborations with leading pharmaceutical companies for various projects. Saniona’s ion channel discovery platform is further validated through research collaborations with companies like Boehringer Ingelheim.
Average Trading Volume: 1,289,825
Technical Sentiment Signal: Buy
Current Market Cap: SEK2.25B
Find detailed analytics on SANION stock on TipRanks’ Stock Analysis page.